LAMP3 and endometrial cancer: The overexpression rates of PD-1 (CD279) and PD-L1 (CD274) in endometrial cancer have been reported to be the highest of all gynaecological cancers, so we evaluated LAMP3 expression levels and the correlation of multiple immune checkpoints in detail.